|Issue 1022: October 30, 2012
EDUCATION AND TRAINING
Reminder: October 2012 issues of Needle Tips and Vaccinate Adults available online
The October 2012 issues of Needle Tips and Vaccinate Adults are available online. Vaccinate Adults is an abbreviated version of Needle Tips with the pediatric content removed.
Click on the images below to download the entire October 2012 issues (PDF) of Needle Tips and/or Vaccinate Adults.
ACIP votes to recommend that pregnant women receive Tdap vaccination during each pregnancy
On October 24, at its regularly scheduled October meeting, CDC's Advisory Committee on Immunization Practices (ACIP) voted to recommend that pregnant women receive Tdap vaccine during each pregnancy even if a woman has received the vaccine previously. A related CDC media advisory issued on the same date is reprinted below.
CDC Advisory Committee for Immunization Practices Recommends Tdap Immunization for Pregnant Women
The Advisory Committee on Immunization Practices voted today 14 to 0, with one abstention, to recommend that providers of prenatal care implement a Tdap immunization program for all pregnant women. Health-care personnel should administer a dose of Tdap during each pregnancy irrespective of the patient’s prior history of receiving Tdap. If not administered during pregnancy, Tdap should be administered immediately postpartum.
This builds upon a previous recommendation made by ACIP in June 2011 to administer Tdap during pregnancy only to women who have not previously received Tdap. By getting Tdap during pregnancy, maternal pertussis antibodies transfer to the newborn, likely providing protection against pertussis in early life, before the baby starts getting DTaP vaccines. Tdap will also protect the mother at time of delivery, making her less likely to transmit pertussis to her infant. If not vaccinated during pregnancy, Tdap should be given immediately postpartum, before leaving the hospital or birthing center.
The U.S. remains on track to have the most reported pertussis cases since 1959, with more than 32,000 cases already reported along with 16 deaths, the majority of which are in infants.
Note: ACIP’s recommendations will be forwarded to CDC’s director for approval. If the ACIP recommendations are approved by the CDC director, they will be published in CDC’s Morbidity and Mortality Weekly Report (MMWR) and represent the official CDC recommendations for immunizations in the U.S.; until then, they are considered provisional.
Back to top
ACIP votes to recommend meningococcal vaccination for high-risk infants starting at age 2 months
Meningococcal disease is a serious, vaccine-preventable bacterial infection caused by Neisseria meningitidis bacteria. The two most severe common illnesses caused by these bacteria include meningitis and bloodstream infections. Infants with certain medical conditions, such as sickle cell disease or complement component deficiency, are at increased risk for meningococcal disease.
Meningococcal disease incidence has declined to historically low levels since the last peak in disease in the late 1990s. About 50 of infant cases are potentially preventable by available vaccines. The majority of infant cases are caused by a type of the bacteria that are not prevented by meningococcal vaccines. Also, the majority of infant cases occur within the first 6 months of life, before a vaccine would likely be able to protect since 3 doses are needed (at 2, 4 and 6 months) to maximize the immune response.
New: Sixth edition of Vaccines, the definitive vaccine textbook, now available for order
Edited by esteemed vaccine scientists Stanley A. Plotkin, MD; Walter A. Orenstein, MD; and Paul A. Offit, MD, the sixth edition contains key features that, according to Elsevier, will enable readers to
Priced at $287.20, Vaccines contains 1,392 pages. Order online, or access information for ordering by phone or mail by scrolling down to the subhead titled "Books Customer Service Department."
Back to top
Spotlight on immunize.org: subscribe to immunization-related email news services from CDC, AAP, VEC, and more
The Email News Services web section on immunize.org includes descriptions and subscription information for more than 25 immunization-related e-newsletters and email updates published by governmental and non-governmental agencies, professional societies, academic centers, and nonprofit organizations.
CDC publishes information about two-dimensional vaccine barcoding
CDC recently published Two-Dimensional (2D) Vaccine Barcoding on its Immunization Information Systems (IIS) web section. The report includes results from a study assessing the potential impact of 2D barcodes for vaccine production, clinical development, and public health reporting and tracking, and a pilot project to test 2D barcode implementation.
Currently, vaccine product identification and vaccine lot numbers are either handwritten or typed into an electronic medical record and/or IIS system, and are frequently missing or incorrect. Implementation of a 2D barcode on vaccines could allow for rapid and accurate entry of these data (and more) by a handheld imaging device or scanner.
Back to top
IAC updates its healthcare professional Q&A "Hepatitis B and Healthcare Personnel"
IAC recently revised its three-page Q&A resource from CDC immunization experts titled Hepatitis B and Healthcare Personnel: CDC answers frequently asked questions about how to protect healthcare personnel. Revisions were made throughout the document, including the table.
IAC's Handouts for Patients & Staff web section offers healthcare professionals and the public more than 250 FREE English-language handouts (many also available in translation), which we encourage website users to print out, copy, and distribute widely.
Back to top
IAC updates six standing orders templates for vaccine administration
Back to top
California's new interactive training on conducting a vaccine inventory available to all
The Immunization Branch of the California Department of Public Health (CDPH) recently posted a 19-minute interactive training module on its EZIZ website. Developed by EZIZ for the use of medical assistants who work for California's Vaccines for Children (VFC) providers, the Conducting a Vaccine Inventory module is accessible to anyone who clicks on the hyperlinked text above, then clicks on the text by the same name on the EZIZ website, and logs in (log in is free).
The CDPH immunization skills training portal, EZIZ, provides interactive immunization lessons, job aids, and updated vaccine news and information of interest to California's VFC providers and others involved in immunization in other parts of the nation.
Back to top
MMWR iPad app available for free download
CDC publishes report on recent progress Chad made toward eradicating polio
CDC published Progress Toward Poliomyelitis Eradication—Chad, January 2011–August 2012 in the October 26 issue of MMWR (pages 858–862). The first paragraph is reprinted below.
In 1988, the World Health Assembly launched the Global Polio Eradication Initiative (GPEI) to interrupt transmission of wild poliovirus (WPV). By January 2012, indigenous WPV transmission had been interrupted in all countries except Afghanistan, Pakistan, and Nigeria. However, importation of WPV caused outbreaks in 29 and reestablished transmission in four, previously polio-free African countries during 2003–2011. Transmission after WPV importation is considered reestablished when it continues for ≥12 months; in Chad, transmissions of WPV type 3 (WPV3) and WPV type 1 (WPV1) were reestablished. WPV3 was imported from Nigeria in 2007 and continued to circulate; the latest reported WPV3 case occurred on March 10, 2011. Transmission of WPV1 continued after a WPV1 case was imported from Nigeria in September 2010; the latest reported WPV1 occurred on June 14, 2012. This report updates previous reports and describes polio eradication activities and progress in Chad during January 2011–August 2012, as of October 2, 2012. Five WPV1 cases were reported during January–August 2012, compared with 111 WPV1 cases and three WPV3 cases reported during the same period in 2011. Five circulating type 2 vaccine-derived poliovirus (cVDPV2) cases occurred during July–August 2012. Current progress suggests that Chad could interrupt reestablished WPV transmission in 2012, although limitations in surveillance hamper the ability to detect ongoing transmission. Furthermore, with ongoing endemic WPV transmission in Nigeria, Chad remains at risk for new WPV importations. Efforts to strengthen surveillance and enhance routine and campaign immunization performance will need to continue in Chad to ensure interruption of reestablished WPV transmission, limit circulation after any WPV importation, and interrupt transmission of cVDPV.
Back to top
EDUCATION AND TRAINING
Medscape features CDC expert explaining new ACIP recommendations to give PCV13 to high-risk adults
In a new Medscape video, CDC expert Tamara Pilishvili, MPH, talks about the new ACIP recommendations to give PCV13 (Prevnar 13) to high-risk adults and reviews existing PPSV23 (Pneumovax) recommendations for adults. This free overview is a must-see for every doctor, nurse, and healthcare provider who provides medical care to adults. Use of Medscape is free, but you must register to gain access to the resources.
IZ Express is supported in part by Grant No. 1NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer
Editor-in-ChiefKelly L. Moore, MD, MPH
Managing EditorJohn D. Grabenstein, RPh, PhD
Associate EditorSharon G. Humiston, MD, MPH
Writer/Publication CoordinatorTaryn Chapman, MS
Courtnay Londo, MA
Style and Copy EditorMarian Deegan, JD
Web Edition ManagersArkady Shakhnovich
Contributing WriterLaurel H. Wood, MPA
Technical ReviewerKayla Ohlde